The purpose of this study is to explore the usage frequency of the decision support instruction in the nursing information system, and to survey the technology acceptance among nurses in one hospital. The results indicated that the usage frequency of the care instruction was increased from 191.3 to 1308.5 per month. Nurses also rated the "perceived usefulness" the highest score, followed by "perceived ease of use" in the survey.
Download full-text PDF |
Source |
---|
Neth Heart J
January 2025
Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
The European Society of Cardiology (ESC) has updated its guidelines on cardiac pacing and cardiac resynchronisation. As the majority are class II recommendations (61%) and based on expert opinion (59%), a critical appraisal for the Dutch situation was warranted. A working group has been established, consisting of specialists in cardiology, cardiothoracic surgery, geriatrics, allied professionals in cardiac pacing, and patient organisations with support from the Knowledge Institute of the Dutch Association of Medical Specialists.
View Article and Find Full Text PDFEnviron Sci Pollut Res Int
January 2025
LEESU, Ecole des Ponts Paris Tech, UPEC, AgroParisTech, F-77455 Marne-la-Vallée, Paris, France.
Urban reservoirs are frequently exposed to impacts from high population density, polluting activities, and the absence of environmental control measures and monitoring. In this study, we investigated the use of satellite imagery to assess restoration measures and support decision-making in a hypereutrophic urban reservoir. Since 2016, Lake Pampulha (Brazil) has undergone restoration measures, including the application of Phoslock®, to mitigate its poor water quality conditions.
View Article and Find Full Text PDFAnn Hematol
January 2025
Hematology and Hematopoietic Stem Cell Transplant Center, Department of Medicine and Surgery, University of Naples Federico II, Via S. Pansini 5, Naples, 80131, Italy.
Splenomegaly is a quite common clinical feature of Philadelphia (Ph) negative chronic myeloproliferative neoplasms (MPNs) and its presence may, in some cases, drives treatment decision. Most importantly, palpable splenomegaly is a minor criterion for both pre-fibrotic/early primary myelofibrosis and primary myelofibrosis (PMF) diagnosis, even if clinical assessment by physical examination is poorly reliable and accurate. On the other hand, despite the International Working Group-Myeloproliferative Neoplasms Research and Treatment and European LeukemiaNet guidelines defined spleen response criteria by palpation, they also recognized the highly subjective nature of spleen size assessment by physical examination, and recommended objective confirmation of volume reduction via computed tomography or magnetic resonance imaging (MRI).
View Article and Find Full Text PDFNurs Educ Perspect
January 2025
About the Authors The authors are faculty, School of Nursing, Notre Dame of Maryland University, Baltimore, Maryland. Katelyn A. Quarry, DNP, RN, CCRN, CNE, is assistant professor. Rodnita K. Davis, PhD, RN, CNE, is associate professor. Kathryn Handy, DNP, RN, CNE, is assistant professor. Tina L. Bloom, PhD, MPH, RN, is associate professor and Frances K. Pitts '96 Endowed Chair in Leadership in Women's and Children's Health. Intramural funding from the Kay Pitts '96 endowment supported this research. For more information contact Dr. Quarry at
Cohen scholars (CS) is a Maryland scholarship program aimed to increase the number of qualified nurse educators and ease the nurse faculty shortage. Nurses pursuing graduate degrees may apply for scholarships in exchange for service as educators in a faculty or clinical educator role. This study was conducted to understand the career decision-making processes of recent CS graduates and facilitators and barriers to assuming a faculty role.
View Article and Find Full Text PDFJ Comp Eff Res
January 2025
Department of Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany.
exon 14 ex14) skipping occurs in 3-4% of non-small-cell lung cancer (NSCLC) cases. Low frequency of this alteration necessitated open-label, single-arm trials to investigate MET inhibitors. Since broad MET biomarker testing was only recently introduced in many countries, there is a lack of historical real-world data from patients with ex14 skipping NSCLC receiving conventional therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!